1. Abe E, Miyaura C, Sakagami H, Takeda M, Konno K, Yamazaki T, Yoshiki S, Suda T (1981) Differentiation of mouse myeloid leukaemia cells induced by 1a,25-dihydroxyvitamin D3. Proc Nat Acad Sci U S A 78:4990–4994
2. Abe-Hashimoto J, Kikuchi T, Matsumoto T, Nishii Y, Ogata E, Ikeda K (1993) Anti-tumor effect of 22-oxa-calctriol, a non-calcaemic analogue of calcitriol in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen. Cancer Res 53:2534–2537
3. Bartek J, Bartkova J, Lukas J (1996) The retinoblastoma protein and the restriction point. Curr Opin Cell Biol 8:805–814
4. Beech DJ, Parekh N, Pang Y (2001) Insulin-like growth factor-I receptor antagonism results in increased cytotoxicity of breast cancer cells to doxorubicin and Taxol. Oncol Rep 8:325–329
5. Berger U, Wilson P, McClelland R, Colston K, Haussler MR, Pike JW, Coombes RC (1987) Immunocytochemical detection of 1,25-dihydroxyvitamin D3receptor in primary breast cancer. Cancer Res 47:6793–6795